Pharma News
-
Phebra to collaborate with University of Wollongong for cancer studies
Pharma | News | 0 Comment | 16 Apr, 2019
Australian pharmaceutical firm, Phebra, has announced a collaboration and licensing agreement with the University of Wollongong (UOW) to continue development of newly patented arsenic ...Read more
-
Catalent opens second clinical supply facility in Shanghai
Pharma | News | 0 Comment | 12 Apr, 2019
Catalent Pharma Solutions, a global leader in clinical supply services has announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China. The event was...Read more
-
Pharma | News | 0 Comment | 11 Apr, 2019
CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo – takes place at the Shanghai New International Expo Center (SNIEC...Read more
-
Shionogi licenses Symproic to BioDelivery Sciences International Inc.
Pharma | News | 0 Comment | 11 Apr, 2019
Shionogi, Japanese major research-driven pharmaceutical company dedicated to bringing benefits to patients has announced that BioDelivery Sciences International, a rapidly gr...Read more
-
Kaken Pharma, HitGen to develop a novel class of drugs
Pharma | News | 0 Comment | 12 Apr, 2019
HitGen has announced that HitGen Inc. and Kaken Pharmaceutical have entered into a license agreement to develop a novel class of drugs. The licensed compounds were identified using Hit...Read more
-
Mallinckrodt's INOmax receives approval in Australia
Pharma | News | 0 Comment | 11 Apr, 2019
Mallinckrodt plc a leading global specialty pharmaceutical company has announced that INOmax™ (nitric oxide) gas, for inhalation has received regulatory approval in ...Read more
-
Uni-Bio Science appoints Zhao Zhi Gang as CEO
Pharma | News | 0 Comment | 09 Apr, 2019
A fully integrated biopharmaceutical company Uni-Bio Science Group Limited has announced the appointment of Mr. Zhao Zhi Gang as the CEO, Mr. Ma Qing Shan as i...Read more
-
Ascentage Pharma collaborates with Junshi Bioscience for cancer therapy
Pharma | News | 0 Comment | 09 Apr, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases has announced that it...Read more
-
Hope Med signs global agreement with Bayer AG
Pharma | News | 0 Comment | 08 Apr, 2019
Hope Medicine has signed a world-wide exclusive license agreement with Bayer AG on the development and commercialization of a human antibody targeting the PRL receptor for the treatment of ...Read more
-
Sun Pharma launches INFUGEM in the U.S.
Pharma | News | 0 Comment | 08 Apr, 2019
India-based Sun Pharmaceutical Industries Ltd. has announced that INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially availabl...Read more
-
Everstone to sell controlling stake in Rubicon Research
Pharma | News | 0 Comment | 08 Apr, 2019
Everstone is a premier investment group focused on India and South East Asia. Everstone Group’s Singapore fund, will sell its entire stake in Rubicon Research (Rubicon) to a global pr...Read more
-
Cytovant Sciences to develop cellular therapies in Asia
Pharma | News | 0 Comment | 05 Apr, 2019
Sinovant Sciences and Roivant Sciences have announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular therapeutics...Read more
-
West Pharma expands APAC biz with new Korean office
Pharma | News | 0 Comment | 05 Apr, 2019
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, has expanded its presence in the Asia Pacific region with a new sales office i...Read more
-
Clinigen K.K., GC Pharma sign pact to market Hunterase ICV
Pharma | News | 0 Comment | 05 Apr, 2019
Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize Hunterase (Idursulfase-beta) ICV, a human recombinant iduronate-2-su...Read more
-
Japan approves first drug for ADA deficiency
Pharma | News | 0 Comment | 04 Apr, 2019
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acquired marketing approval for Revcovi 2.4 mg for intramuscular injection...Read more
-
Harvest One enters into supply agreement with Health House
Pharma | News | 0 Comment | 04 Apr, 2019
Harvest One Cannabis Inc. through its wholly-owned subsidiary Satipharm Ltd. has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distr...Read more
-
Chugai Pharma sells Ulcerlmin business to Fuji Chemical
Pharma | News | 0 Comment | 03 Apr, 2019
Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies entered into a business transfer agreement recently for Ulcerlmin®...Read more
-
Aptorum Group Limited announces appointment of Head of R&D and COO
Pharma | News | 0 Comment | 02 Apr, 2019
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr. Angel Siu-yan Ng as Chief Operating Officer of Aptorum, effective o...Read more
